Combining a Nutrient Program with Conventional Treatment May Work Best for Prostate CancerNutrition — By nygal on October 25, 2009 at 8:26 am
(HealthNewsDigest.com) – Conventional approaches to prostate cancer focus on attacking and destroying it with procedures such as seed implant, radical prostatectomy, radiation therapy, cryotherapy or hormonal therapy. These approaches are not always successful at eradicating the disease and are often associated with side effects that severely impact quality of life. In addition, these approaches do not support the overall health and vitality of the patient.
The goal of integrative medicine, on the other hand, is to support a person’s health and vitality while reducing the disease. Conventional treatments can be complemented by nutrients to boost the immune system, modulate hormones, usher the toxins out of the body and much more. In some cases, nutrients have shown promise in preventing and controlling prostate cancer.
The Power of Nutrients
Studies have shown that combining nutrients that have different mechanisms of action in effective amounts attacks the cancer from all sides at once. In addition to their anticancer properties, many nutrients have specific health-promoting properties. These nutrients can be categorized according to their beneficial principles:
Prevention of cancer metastasis
Detoxification and liver support
By selecting nutrients which have multiple mechanisms of action, we create a program which simultaneously impacts the cancer cells from a number of angles and supports the patient’s immune response, creating an beneficial additive effect.
One nutrient with multiple beneficial properties is Modified Citrus Pectin (MCP). For this reason, it is one of the foundational supplements we incorporate for treatment of prostate cancer at our clinic. Research both in vitro and in vivo has shown that a specific Modified Citrus Pectin product (PectaSol-C® MCP) administered in dosages of 5 grams three times daily following prostatectomy, radiation or cryosurgery can increase the rate of prostate specific antigen (PSA) doubling in men with prostate cancer, slowing disease progression.
Earlier research at Wayne State University demonstrated that MCP, when given orally, had an inhibitory effect on carbohydrate-mediated tumor growth, angiogenesis and metastasis in vivo, and showed a dose-dependent inhibition of tumor angiogenesis on breast and colon cancer cell cultures using human umbilical vein endothelial cells in vitro.
Please read the complete article and let us know what you think below.